Valuation: Abera Bioscience AB

Market Cap 182M 18.93M 16.54M 15.26M 14.07M 26.52M 1.82B 27.11M 71.76M 893M 71.08M 69.52M 3.07B P/E 2024
-64.4x
P/E 2025 -10.8x
Enterprise Value 159M 16.49M 14.41M 13.3M 12.26M 23.1M 1.59B 23.62M 62.52M 778M 61.93M 60.57M 2.68B EV / Sales 2024
4.32x
EV / Sales 2025 8.6x
Free-Float
40.83%
Yield 2024 *
-
Yield 2025 -
1 day+0.45%
1 week+5.70%
Current month-5.32%
1 month-2.20%
3 months+27.14%
6 months+41.27%
Current year+30.88%
1 week 7.5
Extreme 7.5
8.98
1 month 7.5
Extreme 7.5
10.05
Current year 5.15
Extreme 5.15
10.05
1 year 5.15
Extreme 5.15
10.05
3 years 3.24
Extreme 3.24
10.05
5 years 3.05
Extreme 3.05
30.8
10 years 3.05
Extreme 3.05
30.8
Manager TitleAgeSince
Chief Executive Officer 43 2020-09-30
Chief Tech/Sci/R&D Officer 66 2012-11-02
Chief Tech/Sci/R&D Officer 61 2022-04-30
Director TitleAgeSince
Director/Board Member 74 2019-12-31
Chairman 56 2014-12-31
Director/Board Member 59 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
1/21/22 Buy

Chairman

12,000 0.1147%
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%+5.70%+21.92%+118.14% 18.93M
+3.90%-0.39%+376.72%+599.59% 39.58B
-1.70%+4.46%+7.46%+57.67% 34.69B
-2.01%-0.76%+26.35%-6.83% 34.42B
+0.06%+0.34%+2.32%+29.30% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+68.48%+117.39% 15.36B
+1.12%+1.91%+15.90%+19.65% 14.05B
0.00%+1.36%+15.74%-30.62% 13.02B
-0.08%-3.01%+1,271.69%+649.69% 11.76B
Average +0.22%+0.65%+200.73%+172.66% 20.62B
Weighted average by Cap. +0.24%+0.36%+171.42%+187.41%

Financials

2024 2025
Net sales 14.63M 1.52M 1.33M 1.22M 1.13M 2.13M 146M 2.17M 5.75M 71.58M 5.7M 5.57M 246M 11.85M 1.23M 1.07M 992K 914K 1.72M 118M 1.76M 4.66M 57.99M 4.62M 4.52M 200M
Net income -1.1M -114K -99.73K -92.03K -84.83K -160K -10.99M -163K -433K -5.38M -429K -419K -18.53M -10.45M -1.08M -948K -875K -806K -1.52M -104M -1.55M -4.11M -51.15M -4.07M -3.98M -176M
Net Debt -6.09M -632K -552K -510K -470K -885K -60.85M -905K -2.4M -29.8M -2.37M -2.32M -103M -23.49M -2.44M -2.13M -1.97M -1.81M -3.41M -235M -3.49M -9.24M -115M -9.15M -8.95M -396M
Logo Abera Bioscience AB
Abera Bioscience AB is a Sweden-based company, which is active in biotechnology. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.
Employees
6
Date Price Change Volume
26-07-17 SEK 8.900 +0.45% 748
26-07-16 SEK 8.860 +2.07% 7,874
26-07-15 SEK 8.680 -0.91% 1,776
26-07-14 SEK 8.760 +4.53% 8,994
26-07-13 SEK 8.380 -0.48% 4,438

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABERA Stock